Description |
1 online resource |
Series |
Neurology - Laboratory and Clinical Research Developments |
Contents |
PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL): INCIDENCE, MANAGEMENT AND OUTCOMES ; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL): INCIDENCE, MANAGEMENT AND OUTCOMES ; CONTENTS ; PREFACE ; I. EPIDEMIOLOGY, PATHOLOGY AND BIOLOGY ; Chapter 1 EPIDEMIOLOGY OF PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA ; ABSTRACT ; INTRODUCTION ; EPIDEMIOLOGY OF PCNSL; Overall PCNSL Incidence ; PCNSL Incidence Is Higher in Males Than in Females ; PNSCL Incidence Increases with Advancing Age ; Country-Specific Increases in PCNSL Incidence ; Immunodeficiency Is a Risk Factor for PCNSL ; CONCLUSION |
|
CONCLUSION REFERENCES ; II. DIAGNOSIS ; Chapter 5 DIAGNOSTIC IMAGING OF PRIMARY CENTRAL NERVOUS SYSTEM MALIGNANT LYMPHOMA ; ABSTRACT ; INTRODUCTION; CT AND MRI IN THE DIAGNOSIS OF PCNSL ; FDG PET IN THE DIAGNOSIS OF PCNSL ; Primary Diagnosis and Differentiation from Nontumorous Lesions ; Differentiation from Other Malignant Brain Tumors ; Diagnosis of Atypical PCNSL ; CONCLUSION ; REFERENCES ; Chapter 6 CEREBROSPINAL FLUID INTERLEUKIN-10 (IL-10) AS A DIAGNOSTIC MARKER IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA ; ABSTRACT; INTRODUCTION ; IL-10 IS A USEFUL DIAGNOSTIC MARKER FOR PCNSL |
|
1. Case-Control Study 2. Validation Study; CSF IL-10 as a Surrogate Marker for the PCNSL Tumor Status ; Expression and Secretion of IL-10 in PCNSLs ; CSF IL-10 Activates STAT3 Signaling ; Association of CSF IL-10 Levels with Prognosis ; DISCUSSION; Diagnostic Biomarker for PCNSL ; CSF IL-10 and STAT3; CSF IL-10 and Prognosis ; CONCLUSION ; REFERENCES; Chapter 7 GENE EXPRESSION SIGNATURE-BASED PROGNOSTIC RISK SCORE WITH NETWORK STRUCTURE; ABSTRACT ; INTRODUCTION ; METHODS ; Network Clustering ; SSM-PCA; Prognostic Risk Score Based on a Statistical Regression Model ; Evaluation |
Bibliography |
Includes bibliographical references and index |
Notes |
Description based on print version record; title from PDF title page, viewed (07/14/2020) |
Subject |
Lymphomas -- Treatment
|
|
Central Nervous System Neoplasms -- therapy
|
|
HEALTH & FITNESS / Diseases / General
|
|
MEDICAL / Clinical Medicine
|
|
MEDICAL / Diseases
|
|
MEDICAL / Evidence-Based Medicine
|
|
MEDICAL / Internal Medicine
|
|
Lymphomas -- Treatment
|
Form |
Electronic book
|
Author |
Yamanaka, Ryuya, editor
|
LC no. |
2020677715 |
ISBN |
9781634853361 |
|
1634853369 |
|